An image of glasses on top of newspaper
Markets

Agran Libbie Buys 3M Co, Douglas Emmett, Alerian MLP, Sells Martin Midstream Partners LP, SPDR ...

Agran Libbie

  • New Purchases: MMM , DEI , PFE , AGN, IDXX, OKE, ROP,
  • Added Positions:KMI, AMLP, XOM, VTR, MRK, C, QCOM, OXY, MSFT, JPM,
  • Reduced Positions:DCI, COP, V, MCD, AAPL, WFC, NEE, D, UTX, SO,
  • Sold Out:MMLP, XLK, QCP, TGT, NVO, DNKN, XLP, XLE, XLV, AMJ,

For the details of AGRAN LIBBIE's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=AGRAN+LIBBIE

These are the top 5 holdings of AGRAN LIBBIE

  1. Apple Inc ( AAPL ) - 203,808 shares, 6.89% of the total portfolio. Shares reduced by 1.68%
  2. Berkshire Hathaway Inc (BRK.A) - 62 shares, 3.64% of the total portfolio.
  3. Johnson & Johnson ( JNJ ) - 99,493 shares, 2.91% of the total portfolio. Shares reduced by 0.7%
  4. Berkshire Hathaway Inc (BRK.B) - 65,635 shares, 2.57% of the total portfolio. Shares added by 0.43%
  5. Facebook Inc ( FB ) - 74,687 shares, 2.49% of the total portfolio. Shares added by 0.07%

New Purchase: 3M Co ( MMM )

Agran Libbie initiated holdings in 3M Co. The purchase prices were between $174.18 and $193.01, with an estimated average price of $183.45. The stock is now traded at around $196.21. The impact to the portfolio due to this purchase was 0.71%. The holdings were 15,839 shares as of 2017-03-31.

New Purchase: Douglas Emmett Inc ( DEI )

Agran Libbie initiated holdings in Douglas Emmett Inc. The purchase prices were between $36.46 and $40.79, with an estimated average price of $38.36. The stock is now traded at around $38.30. The impact to the portfolio due to this purchase was 0.3%. The holdings were 33,438 shares as of 2017-03-31.

New Purchase: Pfizer Inc (PFE)

Agran Libbie initiated holdings in Pfizer Inc. The purchase prices were between $31.15 and $34.63, with an estimated average price of $33.23. The stock is now traded at around $33.88. The impact to the portfolio due to this purchase was 0.07%. The holdings were 9,178 shares as of 2017-03-31.

New Purchase: Allergan PLC (AGN)

Agran Libbie initiated holdings in Allergan PLC. The purchase prices were between $210.8 and $249.32, with an estimated average price of $232.88. The stock is now traded at around $242.13. The impact to the portfolio due to this purchase was 0.06%. The holdings were 1,060 shares as of 2017-03-31.

New Purchase: IDEXX Laboratories Inc (IDXX)

Agran Libbie initiated holdings in IDEXX Laboratories Inc. The purchase prices were between $115.95 and $154.72, with an estimated average price of $137.84. The stock is now traded at around $162.83. The impact to the portfolio due to this purchase was 0.06%. The holdings were 1,600 shares as of 2017-03-31.

New Purchase: Roper Technologies Inc (ROP)

Agran Libbie initiated holdings in Roper Technologies Inc. The purchase prices were between $184.93 and $213.93, with an estimated average price of $200.48. The stock is now traded at around $216.98. The impact to the portfolio due to this purchase was 0.05%. The holdings were 1,005 shares as of 2017-03-31.

Added: Alerian MLP (AMLP)

Agran Libbie added to the holdings in Alerian MLP by 25.20%. The purchase prices were between $12.48 and $13.29, with an estimated average price of $12.84. The stock is now traded at around $12.60. The impact to the portfolio due to this purchase was 0.09%. The holdings were 150,126 shares as of 2017-03-31.

Added: Merck & Co Inc (MRK)

Agran Libbie added to the holdings in Merck & Co Inc by 82.96%. The purchase prices were between $59.92 and $66.58, with an estimated average price of $63.58. The stock is now traded at around $62.62. The impact to the portfolio due to this purchase was 0.08%. The holdings were 11,918 shares as of 2017-03-31.

Added: Citigroup Inc (C)

Agran Libbie added to the holdings in Citigroup Inc by 49.39%. The purchase prices were between $55.68 and $61.55, with an estimated average price of $59.14. The stock is now traded at around $59.44. The impact to the portfolio due to this purchase was 0.07%. The holdings were 14,972 shares as of 2017-03-31.

Added: EOG Resources Inc (EOG)

Agran Libbie added to the holdings in EOG Resources Inc by 39.85%. The purchase prices were between $93.38 and $105.48, with an estimated average price of $99.72. The stock is now traded at around $92.84. The impact to the portfolio due to this purchase was 0.02%. The holdings were 3,685 shares as of 2017-03-31.

Added: Schlumberger Ltd (SLB)

Agran Libbie added to the holdings in Schlumberger Ltd by 21.49%. The purchase prices were between $76.96 and $87.48, with an estimated average price of $81.77. The stock is now traded at around $72.81. The impact to the portfolio due to this purchase was 0.01%. The holdings were 3,957 shares as of 2017-03-31.

Sold Out: Martin Midstream Partners LP (MMLP)

Agran Libbie sold out the holdings in Martin Midstream Partners LP. The sale prices were between $17.5 and $20.1, with an estimated average price of $18.88.

Sold Out: SPDR Select Sector Fund - Technology (XLK)

Agran Libbie sold out the holdings in SPDR Select Sector Fund - Technology. The sale prices were between $48.36 and $53.43, with an estimated average price of $51.51.

Sold Out: Quality Care Properties Inc (QCP)

Agran Libbie sold out the holdings in Quality Care Properties Inc. The sale prices were between $15.67 and $19.3, with an estimated average price of $17.77.

Sold Out: Target Corp (TGT)

Agran Libbie sold out the holdings in Target Corp. The sale prices were between $53.12 and $73.81, with an estimated average price of $62.23.

Sold Out: Novo Nordisk A/S (NVO)

Agran Libbie sold out the holdings in Novo Nordisk A/S. The sale prices were between $32.98 and $37.06, with an estimated average price of $34.82.

Sold Out: Dunkin' Brands Group Inc (DNKN)

Agran Libbie sold out the holdings in Dunkin' Brands Group Inc. The sale prices were between $50.77 and $57.93, with an estimated average price of $53.66.

Premium Members

This article first appeared on GuruFocus .

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

MMM DEI FB JNJ AAPL

Other Topics

Stocks

Latest Markets Videos